Paul S. Jellinger

13.7k citations

38 papers · 5.4k indexed · 7 hit papers · h-index 23

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 2%
- Lipoproteins and Cardiovascular Health
- Pancreatic function and diabetes

Papers in

Endocrinology, Diabetes and Metabolism 30
- Diabetes Management and Research 19
- Diabetes Treatment and Management 17
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
Pharmacology 6
- Pharmacology and Obesity Treatment 6

Co-authors: Yehuda Handelsman George Grunberger Alan J. Garber Zachary T. Bloomgarden Daniel Einhorn Paul D. Rosenblit Jeffrey I. Mechanick Michael A. Bush
Journals: Endocrine Practice (22 papers)Clinical Cardiology (1 paper)Current Medical Research and Opinion (1 paper)Journal of Clinical Hypertension (1 paper)Journal of Diabetes (1 paper)
Partner nations: United States Australia Czechia

In The Last Decade

Paul S. Jellinger

37 papers receiving 5.1k citations

Hit Papers

7 papers align trajectories log scale

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary 2020 · 411 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Endocrine Practice
2019 Endocrine Practice
2018 Endocrine Practice
2017 Endocrine Practice
2017 Endocrine Practice
2012 Endocrine Practice
2009 Endocrine Practice

Peers

Countries citing papers authored by Paul S. Jellinger

Since Specialization

Citations

This map shows the geographic impact of Paul S. Jellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Jellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Jellinger more than expected).

Fields of papers citing papers by Paul S. Jellinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul S. Jellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Jellinger. The network helps show where Paul S. Jellinger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul S. Jellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul S. Jellinger Line = papers co-authored together Paul S. Jellinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary Endocrine Practice ·Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne	2020	150
2	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary Endocrine Practice ·Alan J. Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Michael A. Bush, Ralph A. DeFronzo, Jeffrey R. Garber, W. Timothy Garvey, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Leigh Perreault, Paul D. Rosenblit, Susan L. Samson, Guillermo E. Umpierrez Hit paper breakdown →	2020	411
3	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez Hit paper breakdown →	2018	377
4	American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines Diabetes Spectrum ·Paul S. Jellinger	2018	35
5	American Association Of Clinical Endocrinologists And American College Of Endocrinology Guidelines For Management Of Dyslipidemia And Prevention Of Cardiovascular Disease - Executive Summary Endocrine Practice ·Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, 李树尘, Vivian Fonseca, И. Колганов, George Grunberger, Chris Guerin, R Thnickarchitekteningenieure, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, 義彦川原田, Donal Smith, Eliot A. Brinton, Sergio Fazio, 雄太長坂, 加藤久代, P. D. M.	2017	143
6	Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile Postgraduate Medicine ·Stanley S. Schwartz, Paul S. Jellinger, Mary E. Herman	2016	18
7	AACE/ACE Comprehensive Diabetes Management Algorithm 2015 Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	2015	179
8	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2015 Executive Summary Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, Jeffrey R. Garber, Yang Junyou, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez	2015	40
9	Treatment of diabetes mellitus: the urgent need for multifactorial interventions. PubMed ·Charles H. Hennekens, Marc A. Pfeffer, John W. Newcomer, Paul S. Jellinger, Alan J. Garber	2014	5
10	American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	2013	240
11	Aace Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice ·Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, 信好藤田, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	2013	318
12	Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes Postgraduate Medicine ·Paul S. Jellinger	2011	13
13	Overcoming Obstacles in Risk Factor Management in Type 2 Diabetes Mellitus Journal of Clinical Hypertension ·Yehuda Handelsman, Paul S. Jellinger	2011	18
14	The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus. PubMed ·Philip T. Levy, Paul S. Jellinger	2010	12
15	Postprandial Dysmetabolism: the Missing Link Between Diabetes and Cardiovascular Events? Endocrine Practice ·David S.H. Bell, James H. O’Keefe, Paul S. Jellinger	2008	67
16	Rumors of My Death Have Been Greatly Exaggerated Paul S. Jellinger	2008	0
17	Metabolic consequences of hyperglycemia and insulin resistance Clinical cornerstone ·Paul S. Jellinger	2007	87
18	American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome Endocrine Practice ·Rhoda H. Cobin, Walter Futterweit, John E. Nestler, Gerald M. Reaven, Paul S. Jellinger, Yehuda Handelsman, Geoffrey P. Redmond, Samuel S. Thatcher	2005	76
19	Acquired hypothyroidism after switching from thyroid USP to levothyroxine Clinical cornerstone ·Paul S. Jellinger	2005	4
20	The American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Dyslipidemia and Prevention of Atherogenesis Paul S. Jellinger, Richard A. Dickey, Alejandro Gómez Muñoz	2000	17

About Paul S. Jellinger

Paul S. Jellinger is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Economics and Econometrics, Geriatrics and Gerontology and Surgery, having authored 38 papers that have together received 5.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipoproteins and Cardiovascular Health (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmacology and Obesity Treatment (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.8k citations), Surgery (1.7k citations), Family Practice (79 citations), Pharmacology (583 citations) and Cardiology and Cardiovascular Medicine (664 citations). Paul S. Jellinger has collaborated with scholars based in United States, Australia and Czechia. Frequent co-authors include Yehuda Handelsman, George Grunberger, Alan J. Garber, Zachary T. Bloomgarden, Daniel Einhorn, Paul D. Rosenblit, Jeffrey I. Mechanick, Michael A. Bush, Lawrence Blonde and Janet B. McGill. Their work appears in journals such as Endocrine Practice, Clinical Cardiology, Current Medical Research and Opinion, Journal of Clinical Hypertension and Journal of Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact